Related Experiment Video
Updated: Jun 27, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Dermatomyositis update
S Grevelink1, S L Moschella, J Kay
1Department of Dermatology and Medicine, Lahey Clinic Medical Center, Burlington, and Harvard Medical School, Boston, Massachusetts.
Abstract:
Dermatomyositis (DM) is an idiopathic, inflammatory myopathy characterized by dermatologic changes, myopathy, some typical serologic findings, and frequent extramuscular involvement. Both children and adults may be affected, with certain features distinct to children. Dermatologic changes may occur without myositis in patients with amyopathic DM. DM has been reported to occur in patients undergoing treatment with certain therapeutic agents or with concomitant infections. DM may be associated with malignant disease in older patients. Newer serologic tests may identify subsets with different clinical patterns and prognoses. Magnetic resonance imaging is increasingly used to identify muscle involvement and to select sites for biopsies. Newer studies provide improving guidance for therapies in steroid nonresponders.
Related Concept Videos
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Pericarditis III: Medical Management